<?xml version="1.0" encoding="UTF-8"?>
<p>The use of highly potent pharmacologic immune suppression severely impairs the ability of liver transplant recipients to mount an effective immune response against reactivating CMV, thereby predisposing them to increased risk of CMV disease [
 <xref ref-type="bibr" rid="CR60">60</xref>]. The severity of immune dysfunction is strongest with lymphocyte-depleting drugs such as anti-CD3 and antithymocyte globulin [
 <xref ref-type="bibr" rid="CR56">56</xref>].
</p>
